The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CTX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy

Saved in:
Bibliographic Details
Published in:Bone (New York, N.Y.) N.Y.), 2009-06, Vol.44, p.S273-S274
Main Authors: Morrin, M.A, Fitzgerald, O, McKenna, M.J, Brady, J.J, Murray, B.F
Format: Article
Language:English
Subjects:
Orthopedics
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2311-a311297c4a28777734f243e7de75843ddb80319c42a89e97ec92cc8874d2a1913
cites
container_end_page S274
container_issue
container_start_page S273
container_title Bone (New York, N.Y.)
container_volume 44
creator Morrin, M.A
Fitzgerald, O
McKenna, M.J
Brady, J.J
Murray, B.F
description
doi_str_mv 10.1016/j.bone.2009.03.481
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20620251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S8756328209007285</els_id><sourcerecordid>20620251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2311-a311297c4a28777734f243e7de75843ddb80319c42a89e97ec92cc8874d2a1913</originalsourceid><addsrcrecordid>eNp9kr-O1DAQhyMEEsvBC1C5QlAk-E927UgICa04WOkEBYtEZ_mcyWaWxA62c6e8Fw-Iw0JDgQu78Pcba_xNUTxntGKU7V6fq1vvoOKUNhUVVa3Yg2LDlBQllzvxsNgoud2Vgiv-uHgS45lSKhrJNsXPYw_EDujQmoHMCQdMC_EdGcHEOaA7kX2ZIIzo8n2CwU8wJWyBdMGcRnAprnRaJiCHA7F-GMwJHHm5P34rD4dXBB2ZTMLf4D2mnoQe5tEkjy0xriVT9AEzYIkJqQ-YMJIuV_H369vGJSyPn65LM0y9IamHYKblafGoM0OEZ3_Oq-Lr9fvj_mN58_nDYf_uprRcMFaavPFG2tpwJfMSdcdrAbIFuVW1aNtbRQVrbM2NaqCRYBturVKybrlhDRNXxYtL3Sn4HzPEpEeMFnKLDvwcNac7Tvl2BfkFtMHHGKDTU8DRhEUzqldB-qxXQXoVpKnQWVAOvbmEILdwhxB0tPmfLLQYwCbdevx__O0_8b8av8MC8eznkJVFzXTkmuov6wSsA0AbSiVXW_ELnyOxCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20620251</pqid></control><display><type>article</type><title>The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CTX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy</title><source>Elsevier</source><creator>Morrin, M.A ; Fitzgerald, O ; McKenna, M.J ; Brady, J.J ; Murray, B.F</creator><creatorcontrib>Morrin, M.A ; Fitzgerald, O ; McKenna, M.J ; Brady, J.J ; Murray, B.F</creatorcontrib><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><identifier>DOI: 10.1016/j.bone.2009.03.481</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Orthopedics</subject><ispartof>Bone (New York, N.Y.), 2009-06, Vol.44, p.S273-S274</ispartof><rights>2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2311-a311297c4a28777734f243e7de75843ddb80319c42a89e97ec92cc8874d2a1913</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Morrin, M.A</creatorcontrib><creatorcontrib>Fitzgerald, O</creatorcontrib><creatorcontrib>McKenna, M.J</creatorcontrib><creatorcontrib>Brady, J.J</creatorcontrib><creatorcontrib>Murray, B.F</creatorcontrib><title>The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CTX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy</title><title>Bone (New York, N.Y.)</title><subject>Orthopedics</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kr-O1DAQhyMEEsvBC1C5QlAk-E927UgICa04WOkEBYtEZ_mcyWaWxA62c6e8Fw-Iw0JDgQu78Pcba_xNUTxntGKU7V6fq1vvoOKUNhUVVa3Yg2LDlBQllzvxsNgoud2Vgiv-uHgS45lSKhrJNsXPYw_EDujQmoHMCQdMC_EdGcHEOaA7kX2ZIIzo8n2CwU8wJWyBdMGcRnAprnRaJiCHA7F-GMwJHHm5P34rD4dXBB2ZTMLf4D2mnoQe5tEkjy0xriVT9AEzYIkJqQ-YMJIuV_H369vGJSyPn65LM0y9IamHYKblafGoM0OEZ3_Oq-Lr9fvj_mN58_nDYf_uprRcMFaavPFG2tpwJfMSdcdrAbIFuVW1aNtbRQVrbM2NaqCRYBturVKybrlhDRNXxYtL3Sn4HzPEpEeMFnKLDvwcNac7Tvl2BfkFtMHHGKDTU8DRhEUzqldB-qxXQXoVpKnQWVAOvbmEILdwhxB0tPmfLLQYwCbdevx__O0_8b8av8MC8eznkJVFzXTkmuov6wSsA0AbSiVXW_ELnyOxCQ</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Morrin, M.A</creator><creator>Fitzgerald, O</creator><creator>McKenna, M.J</creator><creator>Brady, J.J</creator><creator>Murray, B.F</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope></search><sort><creationdate>20090601</creationdate><title>The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CTX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy</title><author>Morrin, M.A ; Fitzgerald, O ; McKenna, M.J ; Brady, J.J ; Murray, B.F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2311-a311297c4a28777734f243e7de75843ddb80319c42a89e97ec92cc8874d2a1913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Orthopedics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morrin, M.A</creatorcontrib><creatorcontrib>Fitzgerald, O</creatorcontrib><creatorcontrib>McKenna, M.J</creatorcontrib><creatorcontrib>Brady, J.J</creatorcontrib><creatorcontrib>Murray, B.F</creatorcontrib><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><jtitle>Bone (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morrin, M.A</au><au>Fitzgerald, O</au><au>McKenna, M.J</au><au>Brady, J.J</au><au>Murray, B.F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CTX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy</atitle><jtitle>Bone (New York, N.Y.)</jtitle><date>2009-06-01</date><risdate>2009</risdate><volume>44</volume><spage>S273</spage><epage>S274</epage><pages>S273-S274</pages><issn>8756-3282</issn><eissn>1873-2763</eissn><pub>Elsevier Inc</pub><doi>10.1016/j.bone.2009.03.481</doi></addata></record>
fulltext fulltext
identifier ISSN: 8756-3282
ispartof Bone (New York, N.Y.), 2009-06, Vol.44, p.S273-S274
issn 8756-3282
1873-2763
language eng
recordid cdi_proquest_miscellaneous_20620251
source Elsevier
subjects Orthopedics
title The clinical utility of measuring C-terminal telopeptide fragments of type II collagen (CTX-II) in patients with rheumatoid and psoriatic arthritis following anti-TNF-alpha therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T07%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20clinical%20utility%20of%20measuring%20C-terminal%20telopeptide%20fragments%20of%20type%20II%20collagen%20(CTX-II)%20in%20patients%20with%20rheumatoid%20and%20psoriatic%20arthritis%20following%20anti-TNF-alpha%20therapy&rft.jtitle=Bone%20(New%20York,%20N.Y.)&rft.au=Morrin,%20M.A&rft.date=2009-06-01&rft.volume=44&rft.spage=S273&rft.epage=S274&rft.pages=S273-S274&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/10.1016/j.bone.2009.03.481&rft_dat=%3Cproquest_cross%3E20620251%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2311-a311297c4a28777734f243e7de75843ddb80319c42a89e97ec92cc8874d2a1913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20620251&rft_id=info:pmid/&rfr_iscdi=true